Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...
Hosted on MSN8d
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sureBoth results wiped significant value from Novo's share price as investors' hopes of finding a superior alternative to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback